GE HealthCare Technologies Inc. $GEHC Shares Acquired by Locust Wood Capital Advisers LLC

Locust Wood Capital Advisers LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,127,495 shares of the company’s stock after acquiring an additional 43,158 shares during the period. GE HealthCare Technologies accounts for approximately 4.2% of Locust Wood Capital Advisers LLC’s portfolio, making the stock its 6th biggest position. Locust Wood Capital Advisers LLC’s holdings in GE HealthCare Technologies were worth $174,497,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of GEHC. Laurel Wealth Advisors LLC purchased a new position in GE HealthCare Technologies during the fourth quarter worth about $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Godfrey Financial Associates Inc. purchased a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $27,000. Montag A & Associates Inc. lifted its holdings in GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after acquiring an additional 175 shares during the last quarter. Finally, Maseco LLP purchased a new position in GE HealthCare Technologies in the fourth quarter worth approximately $29,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on GEHC shares. Jefferies Financial Group reduced their target price on GE HealthCare Technologies from $105.00 to $90.00 in a research report on Thursday, April 30th. Argus cut their price objective on GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Tuesday, May 19th. Barclays reduced their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research note on Monday. Finally, Wells Fargo & Company dropped their price target on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $80.21.

Insiders Place Their Bets

In related news, CFO James Saccaro bought 3,310 shares of the stock in a transaction that occurred on Friday, May 1st. The stock was purchased at an average cost of $60.60 per share, with a total value of $200,586.00. Following the purchase, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This trade represents a 3.93% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Rodney F. Hochman purchased 1,618 shares of GE HealthCare Technologies stock in a transaction on Tuesday, May 12th. The stock was bought at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the transaction, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ? increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have acquired 21,847 shares of company stock valued at $1,361,355. Corporate insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $64.67 on Monday. The firm has a market capitalization of $29.42 billion, a PE ratio of 15.47, a price-to-earnings-growth ratio of 1.46 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The firm’s 50-day moving average is $66.89 and its two-hundred day moving average is $75.52.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter last year, the firm posted $1.01 EPS. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.